Tratamiento artropatía hemofílica de tobillo con trasplante células derivadas de médula ósea con un procedimiento artroscópico en un solo paso.

Fuente
Este artículo es originalmente publicado en:
http://www.ncbi.nlm.nih.gov/pubmed/?term=Treatment+of+Hemophilic+Ankle+Arthropathy+with+One-Step+Arthroscopic+Bone+Marrow-Derived+Cells+Transplantation

http://car.sagepub.com/content/6/3/150.abstract

De:
Buda R1, Cavallo M1, Castagnini F1, Cenacchi A2, Natali S1, Vannini F1, Giannini S1.
Cartilage. 2015 Jul;6(3):150-5. doi: 10.1177/1947603515574286.

Todos los derechos reservados para:
Copyright © 2015 by SAGE Publications

Abstract

OBJECTIVE:

Ankle arthropathy is a frequent and invalidating manifestation of hemophilia. Arthrodesis is the gold standard surgical procedure in end-stage disease, with many drawbacks in young patients. Recent literature has shown increase interest in regenerative procedures in hemophilicarthropathy, which may be desirable to delay or even avoid arthrodesis. The aim of this article is to present five cases of osteochondral lesions inankle hemophilic arthropathy treated with a regenerative procedure: bone marrow-derived cells transplantation (BMDCT).

CONCLUSION:

BMDCT is a promising regenerative treatment for osteochondral lesions in mild ankle hemophilic arthropathy, which may be useful to delay or even avoid ankle arthrodesis. Nevertheless, longer follow-ups and a larger case series are required.